Licensing Portfolio

Licensing Portfolio

Cancer Research Technology has an impressive range of over 200 oncology-focused projects under development and potentially available for licensing.

Search Licensing Portfolio


CRT, Astex Pharmaceuticals and The ICR announce Epigenetic Drug Discovery Collaboration

CRT, Astex Pharmaceuticals and The Institute of Cancer Research, London, have initiated a collaboration to discover and develop drug candidates targeting an undisclosed epigenetic target in a blood cancer with high unmet medical need. Read more ›


AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Location: Dublin, Ireland

4 day event

More info: Event website